Symbols

IRD

Opus Genetics·NASDAQ

--(--)

IRD fundamentals

IRD Q2 2025 Earnings

Opus Genetics (IRD) released its earnings on Aug 13, 2025: revenue was 2.88M (YoY +159.17%), missed estimates; EPS was -0.12 (YoY +60.00%), beat estimates.

Revenue / YoY

2.88M

+159.17%

EPS / YoY

-0.12

+60.00%

Report date

Aug 13, 2025

Earnings

EPS

Revenue

Revenue & Expenses

IRD has released its 2025 Q4 earnings report, with revenue of 3.87M, reflecting a YoY change of -10.16%, and net profit of -16.52M, showing a YoY change of 52.97%. The Sankey diagram below clearly presents IRD's revenue sources and cost distribution.

Key Indicators

Opus Genetics (IRD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Opus Genetics (IRD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Opus Genetics (IRD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Opus Genetics (IRD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown